Introduction
Heat shock proteins play an important role in acquisition of thermotolerance and protection of cells from various stresses including heat or oxidative stress.
With respect to the role of development of thermotolerance, Hsp27, Hsp70 and Hsp90 were well studied 2). Hsps are induced by heat. Among
Hsps, Hsp90 is a highly conserved heat shock protein in animal and plants, and exists abundantly in the cytoplasm in unstressed condition, accounting for 1-2 % in cytoplasmic proteins 3) . Hsp90 is localized mainly in the cytoplasm although small amounts are also localized in the nucleus . Unlike Hsp70, cytoplasmic Hsp90 does not act generally in nascent protein folding . Main difference of Hsp90 from other Hsps are its substrate that Hsp90 binds to 4). These substrates include various signal transduction proteins, kinase, steroid receptors and transcription factors, therefore, Hsp90 plays a key role in maintaining cellular signal transduction networks. In eukaryotic, Hsp90 is essential for cellular survival (Table I) very large C-terminal truncation mainly located in the nucleus in contrast to wild type Hsp90 6) . They suggested that interaction with a nuclear localization signal (NLS) bearing protein may be responsible for the partial nuclear localization, but exact mechanism and function is still unclear .
It has been shown that overexpression of Hsps was recognized in some cancer, and is associated with poor prognosis or resistance to chemotherapy or radiation therapy. Hsp90 is also overexpressed in lung cancer, breast cancer and leukemias 7). The expression was stronger in cancer tissues than non-cancerous Concerning Hsp90, many chaperoned proteins (client proteins) of Hsp90 are associated with cellular proliferation or malignant transformation, therefore, Hsp90 chaperone complex has been focused as targets for cancer therapy. In this setting, recent research revealed that agents that disrupts Hsp90 is influenced by geldanamycin in the competitive inhibition of ATPase activity 4).
The heterocomplex assembly process has been defined. The first step of this process is the formation of an Hsp90-p60-Hsp70 complex, and then p23 binds to this complex in an ATP-dependent manner 17).
This complex is unstable unless p23 or molybdate is present 5). Hsp90 and Hsp70 do not bind to each other, and it has been suggested that p60 make them interact with one another 18). In Hsp90, there are several interaction sites with other proteins. Chaperoning domain that interacts with client proteins such as steroid receptor and kinases is located in the COOH-terminal of Hsp90.
As mentioned above, Hsp90 plays a key role in maintaining signal transduction pathways through formation of stable complex with key proteins or kinases under unstressed condition. Hsp90 contributes more generally to the refolding of denatured proteins under stress such as heat shock.
Effect of Hsp90 chaperone complex inhibitor
The benzoquinone ansamycins herbimycin A (HA), geldanamycin (GA) and radicicol, a macrocy- Thus, it is easily speculated that Hsp90 chaperone complex inhibitors in combination with radiation or/and heat has potential effect on enhancement of radiosensitivity or thermosensitivity. According to the client proteins described below , the effect of instability or degradation of the proteins on radiosensitivity or thermosensitivity will be summarized . (Fig. 2) . Activation of these pathways that leads to the increase in proliferative activity or antiapoptotic signal is closely associated with radioresistance or chemoresistance, thus RTK-related signal transduction pathways has been considered as a molecular target for cancer treatment. Recent investigations revealed that inhibition of RTK and its-related signal transduction pathways resulted in enhancement of radiosensitivity 28, 29) . Actually, C225 (specific antibody for human EGFR), Herceptin (specific antibody for erbB-2) and ZD1839 (EGFR-tyrosine kinase inhibitor ; EGFR-TKI) are now under clinical trials as molecular-target based drugs (Table II) , and synergistic effect on chemotherapeutic drugs has been reported [30] [31] [32] . Preclinical studies demonstrated that EGFR-TKI, C225 and Herceptin in combination with radiation showed enhancement of radiation-induced cell killing through inhibition of RTK-related signal transduction pathways [33] [34] [35] . This also raises the possibility that Hsp90 chaperone complex inhibitors in combination with radiation or heat enhance radiosensitivity and thermosensitivity.
In regard with interaction of Hsp90 chaperone complex inhibitors with RTK, it has been suggested that Hsp90 stabilizes RTK through interaction with its kinase domain, and Hsp90 chaperone complex to treatment in some cancer 44' 45) , thus combined Hsp90 chaperone complex inhibitors with radiation or hyperthermia aiming at inhibition of HIF-1 a activation would be a novel therapeutic approach for resistant tumors to ordinary treatment. 
Conclusions
Hsp90 is overexpressed in cancer cells, and it is suggested that overexpression of Hsp90 is associated with protection of apoptosis induction through maintaining activity of survival signal transduction pathways, thus Hsp90 and its chaperone complex are considered to be a promising molecular target for cancer therapy, especially enhancement of radiosensitivity and / or thermosensitivity. A problem of 
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